Drupal.behaviors.print = function(context) {window.print();window.close();}>
Regulus Grosses a Total of $80.9M from Recent Transactions
November 08, 2012
Regulus Grosses a Total of $80.9M from Recent Transactions
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding
December 20, 2012 / Gene Silencing News
Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News
With Three Years of Cash in the Bank, Regulus Aims for Two INDs by 2014
November 29, 2012 / Gene Silencing News
Regulus Inks microRNA Drugs Collaboration with AstraZeneca
August 16, 2012 / Gene Silencing News
Regulus Selects HCV Drug Candidate, Will Develop without Partner GSK
May 16, 2013 / Gene Silencing News